[1]
2024. SURVEY OF THE SHORT-TERM SAFETY OF  THE VERO CELL COVID-19 VACCINE AMONG CHINESE CITIZENS IN LESOTHO. The Southeast Asian Journal of Tropical Medicine and Public Health. 55, 2 (Mar. 2024), 19–28.